Covered recipient · General Payments record
DALAL ELDICK
General Payments · PY2018–2024
$2,074.04
- Reported across 104 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $289.87 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $139.21 | 9 |
| Astellas Pharma US Inc | $89.28 | 6 |
| Medtronic, Inc. | $29.64 | 1 |
| Biogen, Inc. | $26.35 | 1 |
| Channel Medsystems, Inc. | $5.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $14.44 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140286703 | CMS |
| Astellas Pharma US Inc | $15.12 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140286843 | CMS |
| Astellas Pharma US Inc | $16.56 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140286479 | CMS |
| Astellas Pharma US Inc | $13.65 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140287389 | CMS |
| Astellas Pharma US Inc | $14.68 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140287791 | CMS |
| Astellas Pharma US Inc | $14.83 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140288035 | CMS |
| Biogen, Inc. | $26.35 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104811553 | CMS |
| Channel Medsystems, Inc. | $5.39 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1069173872 | CMS |
| Medtronic, Inc. | $29.64 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116874029 | CMS |
| Novo Nordisk Inc | $21.38 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108581013 | CMS |
| Novo Nordisk Inc | $13.05 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108581619 | CMS |
| Novo Nordisk Inc | $13.75 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108581621 | CMS |
| Novo Nordisk Inc | $5.51 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108580265 | CMS |
| Novo Nordisk Inc | $24.25 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108581615 | CMS |
| Novo Nordisk Inc | $20.40 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108580869 | CMS |
| Novo Nordisk Inc | $17.62 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108582171 | CMS |
| Novo Nordisk Inc | $17.04 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108580559 | CMS |
| Novo Nordisk Inc | $6.21 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108583155 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.